ABBV
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
Recent news mentioning ABBV
- — AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?
- — AbbVie’s Humira Cash Cow Is Shrinking—Can Its Dividend Keep Growing?
- — ABBV Stock Has Returned $62 Billion To Shareholders. Should You Care?
- — AbbVie Announces Positive Topline Results from the Phase 3 CERVINO Trial Showing Etentamig Significantly Improved Response Rate and Progression-Free Survival in Patients with Relapsed/Refractory Multiple Myeloma
- — AbbVie Completes Acquisition of Apogee Therapeutics
- — AbbVie to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
- — AbbVie to Present at the Wells Fargo 21st Annual Healthcare Conference
- — How Is AbbVie’s Stock Performance Compared to Other Healthcare Stocks
- — AbbVie vs. Eli Lilly and: Which Healthcare Stock Is a Better Buy in 2026?
- — AbbVie vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?
- — Lilly, BMS, AbbVie y GSK disparan las operaciones farmacéuticas
- — AbbVie Submits Regulatory Application to EMA for SKYRIZI® (risankizumab) Subcutaneous Induction for Adults with Moderately to Severely Active Crohn's Disease